Production and evaluation of a recombinant subunit vaccine against botulinum neurotoxin serotype B using a 293E expression system.

about

Production and evaluation of a recombinant subunit vaccine against botulinum neurotoxin serotype B using a 293E expression system.

Item

http://www.wikidata.org/entity/Q35886818

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Production and evaluation of a ...... sing a 293E expression system.

@ast

Production and evaluation of a ...... sing a 293E expression system.

@en

type

Item

label

Production and evaluation of a ...... sing a 293E expression system.

@ast

Production and evaluation of a ...... sing a 293E expression system.

@en

prefLabel

Production and evaluation of a ...... sing a 293E expression system.

@ast

Production and evaluation of a ...... sing a 293E expression system.

@en

P1476

Production and evaluation of a ...... sing a 293E expression system.

@en

P2093

DanYang Shi

http://www.w3.org/2001/XMLSchema#string

Shuang Wang

http://www.w3.org/2001/XMLSchema#string

Si Liu

http://www.w3.org/2001/XMLSchema#string

YunZhou Yu

http://www.w3.org/2001/XMLSchema#string

Zheng-Wei Gong

http://www.w3.org/2001/XMLSchema#string

ZhiWei Sun

http://www.w3.org/2001/XMLSchema#string

P2860

High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells

Recombinant production of bacterial toxins and their derivatives in the methylotrophic yeast Pichia pastoris.

Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity

Botulinum and tetanus neurotoxins: structure, function and therapeutic utility

Ganglioside GT1b as a complementary receptor component for Clostridium botulinum neurotoxins

The HCC-domain of botulinum neurotoxins A and B exhibits a singular ganglioside binding site displaying serotype specific carbohydrate interaction.

Neutralizing antibodies of botulinum neurotoxin serotype A screened from a fully synthetic human antibody phage display library.

Purification, potency, and efficacy of the botulinum neurotoxin type A binding domain from Pichia pastoris as a recombinant vaccine candidate.

Development of vaccines for prevention of botulism.

What next for botulism vaccine development?

P304

468-473

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/HV.29714

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25483668

http://www.w3.org/2001/XMLSchema#string

P932

4514161

http://www.w3.org/2001/XMLSchema#string